Immutep (IMMP) Cash from Investing Activities (2011 - 2017)
Immutep (IMMP) posted Cash from Investing Activities of -$3001.1 for Q2 2017, up 93.74% on a QoQ basis from -$47955.5 in Q2 2016, and up 93.74% year-over-year from -$1549.0 in Q2 2016.
Immutep (IMMP) Cash from Investing Activities (2011 - 2017) Analysis & Trends
Immutep's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$3001.1 for Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 172.62 Mn |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -3,001.09 |
| Jun 30, 2017 | -3,001.09 |
| Jun 30, 2016 | -47,955.47 |
| Jun 30, 2016 | -47,955.47 |
| Jun 30, 2011 | -47,582.54 |
| Jun 30, 2011 | -47,582.54 |